UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 3, 2004
BRUKER BIOSCIENCES CORPORATION
(Exact name of registrant as specified in its charter)
|
Delaware |
|
000-30833 |
|
04-3110160 |
|
(State
or other jurisdiction |
|
(Commission |
|
(IRS
Employer |
|
|
|
|
|
|
|
40 Manning Road |
||||
|
(Address of principal executive offices)(Zip Code) |
||||
|
|
|
|
|
|
|
Registrant’s telephone number, including area code: (978) 663-3660 |
||||
Item 12. Results of Operations and Financial Condition
On August 3, 2004, Bruker BioSciences Corporation held a conference call to discuss its results of operations for the three and six months ended June 30, 2004. A copy of the conference call transcript is attached as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.
The information provided in this Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
BRUKER BIOSCIENCES
CORPORATION |
||
|
|
|
||
|
Date: August 10, 2004 |
By: |
/s/ Laura Francis |
|
|
|
|
Laura
Francis |
|
3
Exhibit Index
|
Number |
|
Description |
|
99.1 |
|
Bruker BioSciences Corporation transcript of August 3, 2004 conference call. |
4